Therapnea Labs

Therapy Device for Obstructive Sleep Apnea

Health Tech & Life Sciences
Active
Pre-Funding Netanya, Israel Founded 2013
Website ↗
Last updated 2026-06-18
Total raised
$56K
Last: Grant
Stage
Pre-Funding
Founded
2013
Headcount
6
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

Therapnea Labs is an experienced MedTech company with a novel, patented technology to treat “the silent killer” –Obstructive Sleep Apnea (OSA).

Therapnea is a stent applied inside the patient's mouth from a dental plate that provides mechanical support for the upper airways to prevent airway collapse. The stent is inserted after the patient is asleep and apnea has started.

Therapnea relies on a method to circumvent the gag reflex that, until now, prevented this approach. In a clinical study, Therapnea was validated as being able to circumvent nausea and the gag reflex in 100% of patients and prevent apnea events after the stent was inserted.

The company's proof-of-concept clinical study has shown promising results. The company is also developing a device to prevent snoring, based on the same technology.

Funding history · 1 round · $56K total

Date unknown
Grant $56K
EU Horizon 2020

Q&A

What is Therapnea Labs' primary focus?
Therapnea Labs is a MedTech company developing a novel, patented technology to treat Obstructive Sleep Apnea (OSA) and prevent snoring.
What is the core technology behind Therapnea Labs' solution for Obstructive Sleep Apnea?
Therapnea Labs utilizes a stent applied inside the patient's mouth from a dental plate. This stent provides mechanical support for the upper airways to prevent airway collapse, and it is inserted after the patient is asleep and apnea has started.
What challenge does Therapnea Labs' technology address regarding oral stents?
Therapnea Labs' technology relies on a method to circumvent the gag reflex, which has historically prevented this approach for oral stents.
What were the results of Therapnea Labs' clinical study regarding the gag reflex?
In a clinical study, Therapnea Labs' technology was validated as being able to circumvent nausea and the gag reflex in 100% of patients and prevent apnea events after the stent was inserted.
When was Therapnea Labs founded?
Therapnea Labs was founded in January 2013.
How many employees does Therapnea Labs currently have?
Therapnea Labs has 1-10 employees.
What is the total amount of funding Therapnea Labs has raised?
Therapnea Labs has raised a total of $56,000 through a Grant round.
Which investor participated in Therapnea Labs' Grant funding round?
The EU Horizon 2020 participated in Therapnea Labs' Grant funding round.
Who are the co-founders of Therapnea Labs?
The co-founders of Therapnea Labs are Avi Lior, who serves as Co-founder & CEO, and Noam Hadas, who serves as Director & CTO.

Team · 2

Avi Lior
Founder · Co-founder & CEO
LinkedIn ↗
Noam Hadas
Founder · Director & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Sensing
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2CB2B

Highlights

1 Patents

Tags

sensorsmedical-technologiesapnearespiratorysleep-disordersmedical-devicesstent
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)